Connection
Ryan Fischer to Vancomycin
This is a "connection" page, showing publications Ryan Fischer has written about Vancomycin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.256 |
|
|
|
-
Johnson KM, Fischer RT, Holtmann GJ, Shah A, Alrabadi L, Lewindon P. Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis. Hepatology. 2021 09; 74(3):1716-1717.
Score: 0.200
-
Ali AH, Buness CW, Fischer R, Holtmann GJ, Shah A, Lewindon P, Shah S, Ragnekar AS, Taylor AE, Goel A, Cox KL, Alrabadi L, Wadsworth S, Kulkarni SS, Lindor KD. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology. 2023 06 01; 77(6):E174-E175.
Score: 0.056